MedTrace Logo

Silodosin in Facilitating Flexible Uretroscopy

NCT07068087 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2025-07-16

No results posted yet for this study

Summary

This study aims to provide robust evidence on whether a specific, potent pre-operative medication (silodosin) can make the critical step of ureteral access (UAS placement after dilation) easier and safer during f-URS for kidney stones in non-stented patients, potentially reducing complications and the need for pre-stenting.

Conditions

  • Stone Ureter
  • Stone, Kidney

Interventions

PROCEDURE

Preoperative sioldosin to facilitate ureteric access sheath insertion in RIRS

group A (study group) that included 21 patients who received silodosin 'one capsule 8 mg per day for 1 week preoperatively

PROCEDURE

ureteric access sheath insertion in RIRS without silodosin (Placebo)

group B (study group) that included 21 patients who received Placebo'one capsule per day for 1 week preoperatively

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Mahmoud A. Mohammed, M.D. · Ain Shams University

  • Younan R. Samir, M.D. · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2025-08-10
Completion
2025-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07068087 on ClinicalTrials.gov